rs34637584
|
|
|
0.100 |
GeneticVariation |
BEFREE |
(G2019S) mutation of leucine-rich repeat kinase 2 (LRRK2) is the most common genetic cause of both familial and sporadic Parkinson's disease (PD) cases.
|
22539006 |
2012 |
rs34637584
|
|
|
0.100 |
GeneticVariation |
BEFREE |
G2019S LRRK2 mutation in familial and sporadic Parkinson's disease in Russia.
|
17044089 |
2006 |
rs34637584
|
|
|
0.100 |
GeneticVariation |
BEFREE |
G2019S, the most frequent mutation, is responsible for both familial and sporadic cases of PD.
|
23227859 |
2013 |
rs34637584
|
|
|
0.100 |
GeneticVariation |
BEFREE |
A Y2018F mutation creates a hyperactive phenotype similar to the familial mutation G2019S.
|
31292254 |
2019 |
rs34637584
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Among such pathogenic mutations, Gly2019Ser mutation in the LRRK2 kinase domain is the most frequent cause of familial PD in Caucasians and is also found in some apparently sporadic PD cases.
|
26403521 |
2016 |
rs34637584
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Currently, the Gly2019Ser and Gly2385Arg variants represent the most relevant PD-causing mutation and risk allele, respectively, linking the etiology of the familial and the sporadic forms of this disease.
|
17440812 |
2007 |
rs34637584
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Here, the impact of the p.G2019S mutation of leucine-rich repeat kinase 2 (LRRK2), which is most frequently associated with familial and sporadic PD, on α-synuclein pathology was investigated.
|
30172844 |
2018 |
rs34637584
|
|
|
0.100 |
GeneticVariation |
BEFREE |
In North African populations, G2019S mutation in LRRK2 gene, encoding for the leucine-rich repeat kinase 2, is the most prevalent mutation linked to familial and sporadic Parkinson's disease (PD).
|
28683740 |
2017 |
rs34637584
|
|
|
0.100 |
GeneticVariation |
BEFREE |
In the remaining 251 PD patients (25 familial and 226 sporadic) we found ten additional carriers of the heterozygous p.Gly2019Ser</span> and no carriers of the other mutations.
|
23726462 |
2013 |
rs34637584
|
|
|
0.100 |
GeneticVariation |
BEFREE |
In this study, we compared the effect of striatal injection of high-capacity adenoviral vectors expressing either a kinase-overactive LRRK2 with the familial G2019S mutation or a kinase-inactive LRRK2 variant in young and old C57BL/6J mice.
|
29550548 |
2018 |
rs34637584
|
|
|
0.100 |
GeneticVariation |
BEFREE |
LRRK2, however, is unique among the PD-causing genes, because a missense mutation, G2019S, is a frequent determinant of not only familial but also sporadic PD.
|
19025767 |
2009 |
rs34637584
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Mutations in the LRRK2 gene, the most frequent of which is the G2019S mutation in exon 41, cause familial and sporadic Parkinson's disease (PD) with reduced penetrance.
|
17596714 |
2007 |
rs34637584
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Our data suggest that the LRRK2 G2019S mutation plays an important role in the causality of familial and sporadic Parkinson disease (PD) in Israel and that gender affects its frequency among patients.
|
17938369 |
2007 |
rs34637584
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Owing to the geographic and historic vicinity of Greece with areas of high prevalence of LRRK2 mutations we studied the frequency of the G2019S mutation in a well characterized cohort of familial and sporadic Parkinson's disease patients of Greek origin from mainland Greece.
|
18617409 |
2008 |
rs34637584
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Portugal has been identified as one of the countries with a high prevalence of LRRK2-G2019S, considered to be the most frequent known cause of familial and sporadic Parkinson's disease (PD).
|
28251720 |
2017 |
rs34637584
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Recently, a mutation in the LRRK2 gene, G2019S, was associated with 3-41% and 1-2% of familial and sporadic PD, respectively suggesting a pivotal role of LRRK2 in PD.
|
17880562 |
2007 |
rs34637584
|
|
|
0.100 |
GeneticVariation |
BEFREE |
The "common" LRRK2 G2019S kinase domain substitution has been reported to account for approximately 5% of familial and 1% of sporadic Parkinson disease.
|
16966501 |
2006 |
rs34637584
|
|
|
0.100 |
GeneticVariation |
BEFREE |
The G2019S mutation was found in 6.4% of familial and 3.4% of sporadic cases.
|
16533964 |
2006 |
rs34637584
|
|
|
0.100 |
GeneticVariation |
BEFREE |
The G2019S leucine-rich repeat kinase 2 gene (LRRK2) mutation has been identified in a significant proportion of familial and sporadic cases of Parkinson's disease (PD).
|
17210620 |
2007 |
rs34637584
|
|
|
0.100 |
GeneticVariation |
BEFREE |
The G2019S mutation has been implicated as an important determinant of Parkinson's disease (PD) in both Ashkenazi Jewish and North African Arab populations with carrier frequency of 29.7% among familial and 6% in sporadic Ashkenazi Jewish PD cases.
|
19756366 |
2009 |
rs34637584
|
|
|
0.100 |
GeneticVariation |
BEFREE |
The p.G2019S mutation of the leucine-rich repeat kinase 2 (LRRK2) has been identified as the most prevalent genetic cause of familial and sporadic Parkinson's disease (PD).
|
28826027 |
2017 |
rs34637584
|
|
|
0.100 |
GeneticVariation |
BEFREE |
The frequency of LRRK2 G2019S mutation was 5.8% in familial and 0.5% in sporadic PD cases.
|
30146349 |
2018 |
rs34637584
|
|
|
0.100 |
GeneticVariation |
BEFREE |
The LRRK2 G2019S mutation (c.6055G>A) is the most frequent substitution in Caucasians, accounting for approximately 5-6% of familial and 0.5-2.0% of apparently sporadic PD cases.
|
17235449 |
2007 |
rs34637584
|
|
|
0.100 |
GeneticVariation |
BEFREE |
The LRRK2 G2019S mutation is the most frequent known cause of familial and sporadic Parkinson's disease.
|
19945904 |
2010 |
rs34637584
|
|
|
0.100 |
GeneticVariation |
BEFREE |
The Lrrk2 kinase domain G2019S substitution is the most common genetic basis of familial and sporadic parkinsonism.
|
16437559 |
2006 |